Back to Neurology
Neurologyv2006Evidence-Based

Overall Neuropathy Limitations Scale (ONLS)

Quantifies the severity of functional disability in peripheral neuropathy by assessing upper and lower extremity functional activities. This validated scale is widely used to track disease progression and treatment response in various neuropathic conditions, particularly immune-mediated polyneuropathies.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
onls total score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Overall Neuropathy Limitations Scale (ONLS) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within neurology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

ONLS Total Score = Arms Grade (0-5) + Legs Grade (0-7)

Clinical Pearls & Practice Notes

  • The ONLS is a modified version of the Overall Disability Sum Score (ODSS) with better content validity and reduced ceiling effect
  • Originally validated in 100 patients with various peripheral nerve disorders
  • High inter-rater reliability with intraclass correlation coefficient of 0.97
  • Acceptable responsiveness with standardized response mean of 0.76
  • Best used with direct patient observation rather than patient self-reporting
  • Not validated for use in pediatric populations
  • Particularly useful for tracking progression in immune-mediated polyneuropathies
  • The legs scale includes running and stair climbing to reduce ceiling effects compared to ODSS
  • Should be used in conjunction with other neuropathy assessment tools for comprehensive evaluation
  • Scores of 0-3 generally indicate preserved independence in daily activities
  • Scores ≥7 typically indicate need for mobility aids or assistance
  • Regular monitoring can help assess treatment response and disease progression

Evidence & Literature Citations

  1. Graham RC, Hughes RA. A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry. 2006;77(8):973-6. doi: 10.1136/jnnp.2005.081547.
  2. Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, et al. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol. 2008;7(2):136-44. doi: 10.1016/S1474-4422(07)70329-0.
  3. van Nes SI, Vanhoutte EK, van Doorn PA, Hermans M, Bakkers M, Kuitwaard K, et al. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies. Neurology. 2011;76(4):337-45. doi: 10.1212/WNL.0b013e318208824b.

Score Interpretation Ranges

No Disability0 – 0 pts

No functional limitations

Mild Disability1 – 3 pts

Minimal functional limitations

Moderate Disability4 – 6 pts

Moderate functional limitations

Severe Disability7 – 9 pts

Significant functional limitations

Very Severe Disability10 – 12 pts

Profound functional limitations

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.